Molecular Diagnosis & Therapy
ISSN 1177-1062 · Adis, Springer Healthcare · Switzerland · active 1992–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Molecular Diagnosis & Therapy a predatory journal?
Our screening does not flag Molecular Diagnosis & Therapy. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Molecular Diagnosis & Therapy indexed in Scopus or Web of Science?
Per our venue index, Molecular Diagnosis & Therapy appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Molecular Diagnosis & Therapy's impact?
Papers in Molecular Diagnosis & Therapy are cited about 4.9 times each within two years of publication, and Scimago places it in Q1, with an h-index of 72. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Molecular Diagnosis & Therapy open access?
We hold no reliable open-access classification for Molecular Diagnosis & Therapy. Check the journal's own site for its access model and any article processing charge.